by editor | Sep 2, 2013 | Asides, Blog
BioCryst Pharmaceuticals Inc. – NasdaqGS: BCRX Let’s start with the chart for BCRX: Normally I look at a chart like that and run. The stock was less than two bucks just six weeks ago and now it is over $6. From it’s June low to its August high this stock was...
by editor | Sep 2, 2013 | Asides, Blog
Accelerate Diagnostics Inc. – NasdaqCM: AXDX The insiders have suddenly started huge buys and other acquisitions of shares of AXDX. Directors and board members have acquired 2, 153,650 shares valued at $17,528,114 during August as reported and found on...
by editor | Sep 2, 2013 | Asides, Blog
Astex Pharmaceuticals Inc. – NasdaqGS: ASTX This is one of my favorites, and it has a big move in the past week. The recent sharp move upwards does lead one to holding back on jumping in here necessarily. This becomes one to grab on a pull-back only. However,...
by editor | Sep 2, 2013 | Asides, Blog
Ampio Pharmaceuticals Inc. – NYSE MKT: AMPE The reason I have AMPE on my list is that there is a positive momentum in the news. More importantly, they have just put out the latest release on this in the past 15 days or so. Look at the last two press releases...
by editor | Sep 2, 2013 | Blog, Top, Trade Alert
Listed in: Best Biotech Stocks, Best Penny Stocks, Top Biotech Stocks, Best Biotech Stocks, Penny Stocks Breaking Out, Biotech Stocks Breaking Out Today we are featuring twelve biotech stocks that have been breaking-out in recent weeks. What’s important to...